Medivir AB (publ) (MVRBF) Stock Analysis
DELISTED
What happened to Medivir AB (publ) (MVRBF) stock?
Medivir AB (publ) (MVRBF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $45.8M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Medivir AB (publ) (MVRBF). Medivir AB (publ) is a Swedish biopharmaceutical company focused on oncology. They develop and market treatments for conditions like labial herpes and cutaneous T-cell lymphoma.
Last analyzed: Mar 18, 2026Medivir AB (publ) (MVRBF) Healthcare & Pipeline Overview
MVRBF OTC Market Information
MVRBF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy MVRBF shares?
No. MVRBF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for MVRBF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MVRBF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Medivir AB (publ). An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.